Vagus Nerve Stimulation Market to Observe Utmost CAGR of 15.0% by 2029
Global Vagus Nerve Stimulation Market is the most appropriate, realistic and admirable market research report delivered with a supreme devotion and comprehension of business needs. The most up to date market insights and analysis performed in this marketing report brings marketplace clearly into the focus. Competitive analysis is the major aspect of any market research report and by understanding this many points are covered in the report including strategic profiling of key players in the market, analyse their core competencies, and draw a competitive landscape for the market. With the particular base year and the historic year, certain estimations and calculations are performed in Global Vagus Nerve Stimulation Market report.
The data collected to structure an all-inclusive Global Vagus Nerve Stimulation Market report is based on the data collection modules with large sample sizes. This market report estimates the growth rate and the market value based on market dynamics and growth inducing factors. This report is the best example that encompasses a number of attributes related to market research. The scope of this market report extends from market scenarios to comparative pricing between major players, cost and profit of the specified market regions
The vagus nerve is a long nerve that runs from the brainstem to the abdomen. It plays a role in regulating many bodily functions, including heart rate, blood pressure, and digestion. Vagus nerve stimulation (VNS) is a medical procedure that involves implanting a device that sends electrical pulses to the vagus nerve. This therapy has been shown to be effective in treating a variety of neurological disorders, including epilepsy, depression, and migraine. VNS therapy is a safe and effective treatment for a variety of neurological disorders. It is a minimally invasive procedure that has the potential to improve the quality of life for many patients.
Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-vagus-nerve-stimulation-market&Shri
Growing number of neurological disorders is expected to drive the market’s growth rate
Neurological disorders are a major cause of disability and death worldwide. The prevalence of these disorders is expected to increase in the coming years, due to factors such as aging, obesity, and environmental factors. VNS is a minimally invasive procedure, making it an attractive option for patients reluctant to undergo traditional surgery. VNS therapy has shown promising results in treating various neurological disorders, including epilepsy, depression, and migraine.
Report Scope and Market Segmentation
| Report Metric | Details |
| Forecast Period | 2022 to 2029 |
| Base Year | 2021 |
| Historic Years | 2020 (Customizable to 2014- 2019) |
| Quantitative Units | Revenue in USD Million, Volumes in Units, Pricing in USD |
| Segments Covered | Product Type (Implantable VNS Devices and External VNS Devices), Biomaterial (Ceramics, Metallic, and Polymeric), Application (Pain Management, Epileptic Seizures, Obesity Management, Depression and Anxiety, and Others), Patient Type (Adults, Pediatric, and Geriatric), End User (Hospitals, Ambulatory Surgery Centres, Specialty Centers, and Others) |
| Countries Covered | U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
Major Players
Data Bridge Market Research recognizes the following companies as the major market players: Medtronic (Ireland), LivaNova PLC (U.S.), electroCore, Inc. (U.S.), Cirtec (U.S.), Brain Control Co. Limited (U.K.), Soterix Medical Inc. (U.S.), SetPoint Medical (U.S.), MicroTransponder Inc. (U.S.), Parasym Ltd. (U.K.), and tVNS Technologies GmbH (Germany).
Market Development
- In 2021, MicroTransponder Inc. announced that the U.S. Food and Drug Administration (FDA) had approved the MicroTransponder Vivistim Paired VNS System (Vivistim System), a first-of-its-kind, drug-free rehabilitation system intended to treat moderate to severe upper extremity motor deficits associated with chronic ischemic stroke. The Vivistim System is a small, implantable device that delivers mild electrical pulses to the vagus nerve, which helps to improve movement and function in the affected arm. After receiving FDA approval, MicroTransponder began commercializing the Vivistim System in the United States. The company has since reported strong sales of the device, with revenue from Vivistim sales increasing by 50% in the first quarter of 2023.
- In 2022, Healthtech startup Pulsetto launched a neuromodulation device that stimulates the vagus nerve. The Pulsetto device is a small, wearable device that delivers mild electrical pulses to the vagus nerve, which helps to improve mood, reduce stress, and promote relaxation. The Pulsetto device is based on the principle of vagus nerve stimulation (VNS), which is a minimally invasive therapy that has been shown to be effective in treating a variety of conditions, including epilepsy, depression, and anxiety. VNS works by stimulating the vagus nerve, which is a major nerve that runs from the brain to the stomach.
- In 2019, Electrocore Inc. received FDA approval for gammaCore (nVNS), an nVNS device that is used to treat migraine headaches. The gammaCore device is a small, handheld device that delivers a short burst of electrical stimulation to the vagus nerve. The stimulation is designed to block the transmission of pain signals to the brain. The gammaCore device is a non-invasive alternative to traditional migraine treatments, such as medication and surgery. The device is easy to use and can be used at home or on the go. Electrocore has reported that the gammaCore device has been well-received by patients, and the company is working to expand the device’s availability to patients worldwide.
To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-vagus-nerve-stimulation-market?Shri
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the this research report
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, and geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
Top Key Topics Covered:
- Strategic Imperatives
- Factors Creating Pressure on Growth
- The Strategic Imperative
- Growth Opportunities Fuel the Growth Pipeline Engine
- Research Methodology
- Scope and Segmentation
- Research Context and Scope of Analysis
- Segmentation
- Other Techniques for This Research Report Management
- Growth Opportunity Analysis
- Growth Drivers
- Growth Restraints
- Introduction
- The Impact of the COVID-19 Pandemic and Post
- Future Growth
- Innovation Ecosystem
Continued…
Segment Analysis:
The global vagus nerve stimulation market is categorized into six notable segments based on product type, biomaterial, application, patient type, end user, and distribution channel.
- Based on product type, the market is segmented into implantable VNS devices and external VNS devices. Implantable VNS devices segment is expected to dominate the market with 64.66% market share as it provides efficacy benefits in small studies in refractory migraine and cluster headaches.
- Based on biomaterial, the market is segmented into ceramics, metallic, and polymeric. Metallic segment is expected to dominate the market with 54.64% market share due to its high strength, high fracture toughness, hardness, corrosion resistance, and biocompatibility.
- Based on application, the market is segmented into pain management, epileptic seizures, obesity management, depression and anxiety, and others. Epileptic seizures segment is expected to dominate the market with 48.26% market share due to rise in brain injuries, neurodevelopmental problems, and genetic predispositions.
- Based on patient type, the market is segmented into adults, pediatrics, and geriatrics. Adults segment is expected to dominate the market with a 60.82% market share due to the increased prevalence of neurological disorders.
- Based on end user, the market is segmented into hospitals, ambulatory surgical centers, and specialty centers. Specialty centers segment is expected to dominate the market with 51.09% market share due to the increasing application areas and the rising number of government initiatives.
The hospitals segment will dominate the end user segment of the vagus nerve stimulation market
The hospitals segment will emerge as the dominating segment end user segment. This is because of the growing number of hospitals in the market especially in the developing economies. Further, growth and expansion of research development services on a global scale will further bolster the growth of this segment.
- Based on distribution channel, the market is segmented into direct tender, retail sales, and others. Direct tender segment is expected to dominate the market with 55.46% market share as it creates opportunities and competition in the market and provides a high level of transparency, and distribution of the medical devices are the factors that are expected to drive the market growth.
The direct tender segment will dominate the distribution channel segment of the vagus nerve stimulation market
The direct tender segment will emerge as the dominating segment under distribution channel. This is because of the growing number of infrastructural development activities in the market especially in the developing economies. Further, growth and expansion of the healthcare industry all around the globe will further bolster the growth of this segment.
TOC:
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL VAGUS NERVE STIMULATION MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 LIFELINE CURVE , BY PRODUCT TYPE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
4.3 KEY STRATEGIC INITIATIVES
5 REGULATIONS OF GLOBAL VAGUS NERVE STIMULATION MARKET
6 MARKET OVERVIEW
7 GLOBAL VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE
8 GLOBAL VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL
9 GLOBAL VAGUS NERVE STIMULATION MARKET, BY APPLICATION
10 GLOBAL VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE
11 GLOBAL VAGUS NERVE STIMULATION MARKET, BY END USER
12 GLOBAL VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL
Continued…
Browse Detailed Summary of Research Report with TOC: https://www.databridgemarketresearch.com/toc/?dbmr=global-vagus-nerve-stimulation-market&Shri
Some of the Most Important Questions Scrutinized in the Business Intelligence Report:
- What are the key growth parameters for this global market during the forecast period?
- Which key players are expected to hold the largest market share over the forecast period?
- Who are the leading vendors and manufacturers in this market?
- What are the key strategies adopted by leading players in the market for business development and geographical expansion?
- Which end-use industries can trigger high demand in the market over the forecast period?
- What are the key segments in this market?
- Which regional player will have anticipated leading the global market in terms of size?
- What is the impact of the novel coronavirus pandemic?
- Which obstacles must new players overcome in order to occupy a major position?
Top DBMR Healthcare Reports:
https://www.databridgemarketresearch.com/reports/global-cardasil-treatment-market?Shri
https://www.databridgemarketresearch.com/reports/global-aestheticcosmetic-lasers-market?Shri
https://www.databridgemarketresearch.com/reports/global-yeast-infection-market?Shri
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Editor Details
-
Company:
- The Wire Times
